Remove Collective Remove Programs Remove Therapy
article thumbnail

Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies

Cannabis Law Report

This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. We are excited to explore the potential of emergent psychedelic therapies. ABOUT SANTÉ CANNABIS. Santé Cannabis is at the forefront of safe and supported patient access to complementary medicines.

article thumbnail

Press release: Numinus Launches the Practitioner Certification Pathway – a Complete Psychedelic-Assisted Therapy Training Program

Cannabis Law Report

. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it has launched the Numinus Certification Pathway – a collection of psychedelic-assisted therapy (“PAT”) training courses (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

RYAH Group Ships Devices for Use in Pilot Program with Medicann in Jersey, Channel Islands

Cannabis Law Report

Medicann is launching an observational study using RYAH Smart Dry Herb Inhalers in order to collect patient feedback on consumption of cannabis strains available on the Island, including strains supplied by Aurora Europe , a subsidiary of Canadian-headquartered Aurora Cannabis Inc., to reach 3.2 billion euros ($3.75 billion) by 2025.

article thumbnail

Pennsylvanians Spent $132M On Medical Marijuana In Successful First Year

MassRoots

In 2018, the first full year of operations for the retail medical marijuana program in Pennsylvania, patients spent more than $130 million on the herbal medication. Of the card-holding patients, more than 83,000 purchased products from a dispensary, and more than 600,000 transactions were collectively reported by the licensed dispensaries.

article thumbnail

Weekly Legislative Roundup 2/8/19

NORML

Activists in Mississippi have already collected thousands of signatures in hopes of qualifying a medical cannabis ballot initiative for the 2020 ballot. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. CT resident? CT resident? IA resident?

article thumbnail

Research Shows Strong Support for Natural Therapeutics

Veriheal

Always consult a physician before attempting psychedelic therapy. Data from a nationally representative sample of participants have been collected since 1975 to understand drug use trends among American young adults, and noteworthy findings are published each fall. Cannabis and magic mushrooms for the win! A Magical Future.

article thumbnail

Press Release: PsiloThera, Inc. a Leader in Psychedelic Healthcare Innovation Announces the Filing of U. S. Patents Protecting Its Proprietary Psychedelic Therapeutic Process, Tele-Mental Healthcare & Microdosing Online Platform

Cannabis Law Report

is a pioneering Psychedelic Healthcare Innovation & Life Sciences Company in early stage development of Psilocybin (“Magic Mushroom”) based drugs and therapies proudly announces t he Filing of U. HENDERSON, Nev. , Sept. 9, 2021 /PRNewswire/ — PsiloThera, Inc.